This content is machine translated IL-23-i for psoriasis Real-world studies with a focus on PROs Individual therapy goals are playing an increasingly important role in the modern, guideline-oriented treatment of psoriasis. In this context, real-world studies with biologics often not only record the reduction in…
View Post 11 min This content is machine translated Vitiligo Causes, clinic and therapy Vitiligo is an acquired pigment disorder which leads to a circumscribed loss of pigment due to destruction of the melanocytes. About 1% (0.5-2%) of the world’s population is affected by…
View Post 3 min This content is machine translated Psoriasis Update Systemic therapy is indicated for moderate to severe disease PD Dr. med. Dr. sc. Nat. Alexander Navarini, Department of Dermatology at the University Hospital Zurich, held a workshop on psoriasis at Medidays. Moderate to severe psoriasis can be very…
View Post 5 min This content is machine translated Open questions in psoriasis What does the consensus say? The therapeutic goal in moderate to severe plaque psoriasis is to relieve patients of their skin symptoms as much as possible (PASI ≥75%). If this does not succeed within certain…
